Claudia Bartalucci
Overview
Explore the profile of Claudia Bartalucci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cologgi G, Bartalucci C, Melchio M, Taramasso L, Bruzzone B, Bassetti M, et al.
AIDS Patient Care STDS
. 2025 Feb;
PMID: 39969862
No abstract available.
2.
Ullah N, Fusco L, Ametrano L, Bartalucci C, Giacobbe D, Vena A, et al.
J Clin Med
. 2025 Jan;
14(2).
PMID: 39860395
In immunocompromised patients, pneumonia presents a diagnostic challenge due to diverse etiologies, nonspecific symptoms, overlapping radiological presentation, frequent co-infections, and the potential for rapid progression to severe disease. Thus, timely...
3.
Vena A, Tiseo G, Falcone M, Bartalucci C, Marelli C, Cesaretti M, et al.
Clin Infect Dis
. 2025 Jan;
PMID: 39810592
Background: This study assesses the impact of fluconazole resistance on 30-day all-cause mortality and 1-year recurrence in patients with Candida parapsilosis bloodstream infections (BSI). Methods: A multicenter retrospective study was...
4.
Bassetti M, Stewart A, Bartalucci C, Vena A, Giacobbe D, Roberts J
Expert Opin Drug Metab Toxicol
. 2024 Nov;
21(2):125-132.
PMID: 39552377
Introduction: Rezafungin, formerly SP3025 and CD101, is a next-generation echinocandin, chemically related to anidulafungin, with differentiated pharmacokinetic characteristics, including a prolonged half-life allowing extended-interval dosing. Areas Covered: Herein, we discuss...
5.
Sepulcri C, Bartalucci C, Mikulska M
Curr Opin Infect Dis
. 2024 Oct;
37(6):506-517.
PMID: 39446756
Purpose Of Review: The purpose of this review is to report the available evidence regarding the use of combination regimens of antivirals and/or antibody-based therapy in the treatment of SARS-CoV-2...
6.
Russo C, Mikulska M, Delfino E, Toscanini F, Mezzogori L, Schiavoni R, et al.
Infect Dis Ther
. 2024 Sep;
13(10):2179-2193.
PMID: 39230828
Mycoplasma hominis can be a part of human urogenital tract microbiome, and it is a frequent cause of urogenital infections. In rare cases, it can also cause extragenital infections, especially...
7.
Mora S, Giacobbe D, Bartalucci C, Viglietti G, Mikulska M, Vena A, et al.
J Biomed Inform
. 2024 Jun;
156:104667.
PMID: 38848885
Objectives: Candidemia is the most frequent invasive fungal disease and the fourth most frequent bloodstream infection in hospitalized patients. Its optimal management is crucial for improving patients' survival. The quality...
8.
Labate L, Bartalucci C, Taramasso L, Brucci G, Vena A, Bassetti M, et al.
New Microbiol
. 2024 May;
47(1):111-115.
PMID: 38700892
Lamivudine (3TC)/dolutegravir (DTG) single tablet regimen (STR) has shown long-term efficacy and tolerability in people living with HIV (PLWH). Dolutegravir has been approved for use in children, while data on...
9.
Ricci E, Bartalucci C, Russo C, Mariani M, Saffioti C, Massaccesi E, et al.
J Fungi (Basel)
. 2024 Apr;
10(4).
PMID: 38667947
Background: pneumonia (PJP) has high mortality rates in immunocompromised children, even though routine prophylaxis has decreased in incidence. The aim of this case series is to present the radiological and...
10.
Portunato F, Bartalucci C, Vena A, Giacobbe D, Porcile E, Montanelli P, et al.
Infect Dis Ther
. 2024 Mar;
13(3):625-632.
PMID: 38459236
Amoebic liver abscess is a severe and potentially life-threatening infection requiring prompt diagnosis and early targeted treatment. Diagnosis is challenging because conventional diagnostic methods such as light microscopy and serology...